- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:mp:minocycline [07.04.2014] – paulalbert | home:mp:minocycline [06.27.2015] – [Notes and comments] joyful | ||
|---|---|---|---|
| Line 63: | Line 63: | ||
| Minocycline has been in use for over 40 years yet continues to be effective against MRSA(({{pubmed> | Minocycline has been in use for over 40 years yet continues to be effective against MRSA(({{pubmed> | ||
| - | ===== Combining minocycline with other Marshall Protocol antibiotics ===== | ||
| - | |||
| - | < | ||
| - | |||
| - | //**Trevor Marshall, PhD**//</ | ||
| - | |||
| - | |||
| - | |||
| - | Minocycline may be combined with other MP antibiotics in the following fashion: | ||
| - | |||
| - | * **BCM** – Bactrim DS + clindamycin + minocycline | ||
| - | * **CDM** – clindamycin + demeclocycline + minocycline | ||
| - | * | ||
| - | |||
| - | |||
| - | Because demeclocycline and minocycline are similar, using the antibiotics in the same combination may offer a less severe immunopathological reaction than other combinations. | ||
| Line 112: | Line 96: | ||
| *Legacy content | *Legacy content | ||
| - | * | + | |
| ===== References ===== | ===== References ===== | ||
home/mp/minocycline.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.